Justin Su was a graduate student in the Du Bois group between 2012 and 2017.
Justin worked on synthetic studies towards Pactamycin using oxidative alkene and C–H amination technologies.
In 2017 Justin joined the Reisman Group at CalTech as a postdoctoral scholar.